Skip to main content
Equibles

ALBION FINANCIAL GROUP /UT

Position in IMDX — Insight Molecular Diagnostics Inc.

CIK 1054677 SALT LAKE CITY, UT
Back to IMDX Full portfolio

Position in IMDX

as of Jun 30, 2026 · filed Jul 22, 2026
Position Value
$41
+$19 QoQ
Shares Held
7
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 40 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in IMDX Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

ALBION FINANCIAL GROUP /UT holds $13,727,883 across 8 Diagnostics & Research names. IMDX ranks #8 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 24,162 $12,113,860
2 A
Agilent Technologies, Inc.
 10,160 $1,349,552
3 DHR
Danaher Corp /De/
 1,290 $245,719
4 IDXX
Idexx Laboratories Inc /De
 21 $11,055
5 WAT
Waters Corp /De/
 15 $5,625
6 LH
Labcorp Holdings Inc.
 6 $1,680
7 ILMN
Illumina, Inc.
 2 $351
8 IMDX
Insight Molecular Diagnostics Inc.
This page 		7 $41

All Filings in IMDX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $41 7
2026-03-31 $22 7
2025-12-31 $52 7
2025-09-30 $23 7
2025-06-30 $21 7
2025-03-31 $21 7
2024-12-31 $16 7
2024-09-30 $19 7
2024-06-30 $20 7
2024-03-31 $20 7
2023-12-31 $17 7
2023-09-30 $21 7